Allogene Therapeutics, Inc. SEC filings ALLO
Allogene Therapeutics, Inc. has 585 filings in SEC EDGAR's recent list, going back to Apr 19, 2018. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 27, 2026 | — |
| 4 | Insider transaction | Oct 23, 2026 | Oct 21, 2026 |
| 144 | Notice of proposed sale | Oct 21, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Sep 30, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Sep 2, 2026 | Aug 31, 2026 |
| 4 | Insider transaction | Aug 25, 2026 | Aug 21, 2026 |
| 144 | Notice of proposed sale | Aug 21, 2026 | — |
| EFFECT | Filing | Aug 20, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| S-3 | Shelf registration | Aug 12, 2026 | — |
| 10-Q | Quarterly report | Aug 12, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2026 | Aug 12, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 7, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 7, 2026 | — |
| 4 | Insider transaction | Jul 6, 2026 | Jul 1, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 23, 2026 | Jun 18, 2026 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Jun 22, 2026 | Jun 18, 2026 |
| 424B5 | Prospectus supplement | Jun 22, 2026 | — |
| DEFA14A | Additional proxy material | May 28, 2026 | — |
| 8-K |
Current report
Officer or director change
|
May 28, 2026 | May 28, 2026 |
| DEFA14A | Additional proxy material | May 21, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 13, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 13, 2026 | — |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Material agreement, Agreement ended, Results of operations
|
May 13, 2026 | May 12, 2026 |
| ARS | Annual report to shareholders | Apr 30, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 30, 2026 | — |
| DEF 14A | Proxy statement | Apr 30, 2026 | Jun 18, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 23, 2026 | — |
| 4 | Insider transaction | Apr 23, 2026 | Apr 21, 2026 |
| 144 | Notice of proposed sale | Apr 21, 2026 | — |
| PRE 14A | Preliminary proxy statement | Apr 20, 2026 | Apr 20, 2026 |
| 8-K |
Current report
Other events
|
Apr 15, 2026 | Apr 14, 2026 |
| 424B5 | Prospectus supplement | Apr 15, 2026 | — |
| 424B5 | Prospectus supplement | Apr 13, 2026 | — |
| 8-K |
Current report
Other events
|
Apr 13, 2026 | Apr 13, 2026 |
| 8-K |
Current report
Other events
|
Apr 13, 2026 | Apr 13, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| 144 | Notice of proposed sale | Apr 1, 2026 | — |
| 4 | Insider transaction | Mar 18, 2026 | Mar 16, 2026 |
| 4 | Insider transaction | Mar 18, 2026 | Mar 16, 2026 |
| 144 | Notice of proposed sale | Mar 16, 2026 | — |
| 144 | Notice of proposed sale | Mar 16, 2026 | — |
| S-8 | Employee stock plan registration | Mar 12, 2026 | — |
| 10-K | Annual report | Mar 12, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2026 | Mar 12, 2026 |
| 4 | Insider transaction | Mar 4, 2026 | Mar 2, 2026 |
| 144 | Notice of proposed sale | Mar 2, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Feb 13, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 13, 2026 | — |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 4, 2026 | Feb 2, 2026 |
| 144 | Notice of proposed sale | Feb 2, 2026 | — |
| 144 | Notice of proposed sale | Feb 2, 2026 | — |
| 144 | Notice of proposed sale | Feb 2, 2026 | — |
| 144 | Notice of proposed sale | Feb 2, 2026 | — |
| 144 | Notice of proposed sale | Feb 2, 2026 | — |
| 144 | Notice of proposed sale | Feb 2, 2026 | — |
| 4 | Insider transaction | Jan 23, 2026 | Jan 21, 2026 |
| 144 | Notice of proposed sale | Jan 21, 2026 | — |
| 4 | Insider transaction | Dec 22, 2025 | Dec 18, 2025 |
| 4 | Insider transaction | Nov 19, 2025 | Nov 17, 2025 |
| 144 | Notice of proposed sale | Nov 17, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 13, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 13, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 12, 2025 | — |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 4 | Insider transaction | Oct 23, 2025 | Oct 21, 2025 |
| 144 | Notice of proposed sale | Oct 21, 2025 | — |
| 8-K |
Current report
Other events
|
Oct 14, 2025 | Sep 26, 2025 |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2025 | Aug 13, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 12, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 8, 2025 | — |
| 8-K |
Current report
Other events
|
Aug 1, 2025 | Aug 1, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 16, 2025 | — |
| 4 | Insider transaction | Jun 23, 2025 | Jun 18, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 18, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 18, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 18, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 18, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 18, 2025 |
| 4 | Insider transaction | Jun 23, 2025 | Jun 18, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 23, 2025 | Jun 18, 2025 |
| 4 | Insider transaction | Jun 12, 2025 | Jun 10, 2025 |
| 144 | Notice of proposed sale | Jun 10, 2025 | — |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 13, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 9, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 9, 2025 | — |
| ARS | Annual report to shareholders | Apr 30, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 30, 2025 | — |
| DEF 14A | Proxy statement | Apr 30, 2025 | Jun 18, 2025 |
| 4 | Insider transaction | Apr 23, 2025 | Apr 21, 2025 |
| 144 | Notice of proposed sale | Apr 21, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 17, 2025 | — |
| 4 | Insider transaction | Mar 18, 2025 | Mar 14, 2025 |
| 4 | Insider transaction | Mar 18, 2025 | Mar 14, 2025 |
| 144 | Notice of proposed sale | Mar 14, 2025 | — |
| 144 | Notice of proposed sale | Mar 14, 2025 | — |
| S-8 | Employee stock plan registration | Mar 13, 2025 | — |
| 10-K | Annual report | Mar 13, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 13, 2025 | Mar 13, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 7, 2025 | — |
| 4 | Insider transaction | Mar 5, 2025 | Mar 1, 2025 |
| 3 | Initial insider ownership | Mar 4, 2025 | Mar 1, 2025 |
| 8-K |
Current report
Material agreement
|
Feb 25, 2025 | Feb 19, 2025 |
| 4 | Insider transaction | Feb 20, 2025 | Feb 18, 2025 |
| 144 | Notice of proposed sale | Feb 18, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 13, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 12, 2025 | — |
| 4 | Insider transaction | Feb 5, 2025 | Feb 3, 2025 |
| 4 | Insider transaction | Feb 5, 2025 | Feb 3, 2025 |
| 4 | Insider transaction | Feb 5, 2025 | Feb 3, 2025 |
| 4 | Insider transaction | Feb 5, 2025 | Feb 3, 2025 |
| 4 | Insider transaction | Feb 5, 2025 | Feb 3, 2025 |
| 144 | Notice of proposed sale | Feb 3, 2025 | — |
| 144 | Notice of proposed sale | Feb 3, 2025 | — |
| 144 | Notice of proposed sale | Feb 3, 2025 | — |
| 144 | Notice of proposed sale | Feb 3, 2025 | — |
| 144 | Notice of proposed sale | Feb 3, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Jan 29, 2025 | Jan 23, 2025 |
| 4 | Insider transaction | Jan 28, 2025 | Jan 24, 2025 |
| 4 | Insider transaction | Jan 28, 2025 | Jan 24, 2025 |
| 4 | Insider transaction | Jan 28, 2025 | Jan 24, 2025 |
| 4 | Insider transaction | Jan 28, 2025 | Jan 24, 2025 |
| 4 | Insider transaction | Jan 28, 2025 | Jan 24, 2025 |
| 4 | Insider transaction | Jan 28, 2025 | Jan 24, 2025 |
| 4 | Insider transaction | Jan 23, 2025 | Jan 21, 2025 |
| 144 | Notice of proposed sale | Jan 21, 2025 | — |
| 4 | Insider transaction | Dec 10, 2024 | Dec 9, 2024 |
| 4 | Insider transaction | Dec 9, 2024 | Dec 5, 2024 |
| 144 | Notice of proposed sale | Dec 9, 2024 | — |
| 144/A | Filing | Dec 4, 2024 | — |
| 144 | Notice of proposed sale | Dec 2, 2024 | — |
| 8-K |
Current report
Other events
|
Nov 13, 2024 | Nov 11, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 12, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 8, 2024 | — |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| SC 13G | Ownership over 5% (passive) | Nov 4, 2024 | — |
| 4 | Insider transaction | Oct 23, 2024 | Oct 21, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Oct 22, 2024 | — |
| 144 | Notice of proposed sale | Oct 21, 2024 | — |
| 8-K | Current report | Oct 7, 2024 | Oct 3, 2024 |
| 4 | Insider transaction | Aug 23, 2024 | Aug 21, 2024 |
| 144 | Notice of proposed sale | Aug 21, 2024 | — |
| 10-Q | Quarterly report | Aug 7, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2024 | Aug 7, 2024 |
| 4 | Insider transaction | Jun 20, 2024 | Jun 18, 2024 |
| 144 | Notice of proposed sale | Jun 18, 2024 | — |
| 3 | Initial insider ownership | Jun 11, 2024 | Jun 5, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 10, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 3, 2024 | May 30, 2024 |
| 8-K |
Current report
Material agreement
|
May 31, 2024 | May 24, 2024 |
| 144 | Notice of proposed sale | May 29, 2024 | — |
| 4 | Insider transaction | May 20, 2024 | May 16, 2024 |
| 4 | Insider transaction | May 20, 2024 | May 16, 2024 |
| 4 | Insider transaction | May 20, 2024 | May 16, 2024 |
| 8-K |
Current report
Other events
|
May 14, 2024 | May 13, 2024 |
| 424B5 | Prospectus supplement | May 14, 2024 | — |
| 10-Q | Quarterly report | May 13, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 13, 2024 | May 13, 2024 |
| EFFECT | Filing | Apr 25, 2024 | — |
| 4 | Insider transaction | Apr 24, 2024 | Apr 22, 2024 |
| CORRESP | Letter to the SEC | Apr 23, 2024 | — |
| ARS | Annual report to shareholders | Apr 23, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 23, 2024 | — |
| DEF 14A | Proxy statement | Apr 23, 2024 | Jun 5, 2024 |
| 144 | Notice of proposed sale | Apr 22, 2024 | — |
| UPLOAD | Letter from the SEC | Mar 19, 2024 | — |
| 4 | Insider transaction | Mar 18, 2024 | Mar 14, 2024 |
| S-8 | Employee stock plan registration | Mar 14, 2024 | — |
| S-3 | Shelf registration | Mar 14, 2024 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- ALLO (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- South San Francisco, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1737287
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.